Efficacy and Safety of Α-Lipoic Acid on Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus
Wei-jun GU,Ju-ming LU,Xiao-hong GUAN,Li-xin SHI,Qing-bo GUAN,Yan-gang WANG,Da-jin ZOU,Jia-pu GE,Wei REN,Xiang-hang LUO,Xue-feng YU,Guang-da XIANG,Chun-yan LIU,Yuan-ming XUE,Qiao-yun LUO,Guang-wei LI
DOI: https://doi.org/10.3760/cma.j.issn.1674-5809.2012.07.007
2012-01-01
Abstract:Objective To observe the efficacy and safety of α-lipoic acid(ALA) on diabetic peripheral neuropathy ( DPN ).Methods All of 284 type 2 diabetic inpatients with DPN in sixteen hospitals were selected from August 2009 to March 2010.The patients received ALA 600 mg/d in 250 ml normal saline by intravenous drip infusion once a day for 10 - 14 days.Before and after the management,total symptom score(TSS) was used to evaluate the nervous symptoms,including numbness,sting sensation,burning sensation and hypoesthesia.The clinical data before and after treatment was compared using paired t test.Results Total of 269 patients completed the trial.After at least 10-day treatment,the TSS decreased significantly compared with that at the baseline(3.4 ±2.2 vs 6.7 ±2.6,P＜0.01).The symptom scores of numbness,sting sensation,hypoesthesia and burning sensation reduced significantly after ALA treatment( t =20.82,16.29,16.82,22.49,respectively,all P ＜ 0.01 ).About 99.2％ (267/269) doctors and 97.8％(263/269) patients were satisfied with the treatment effect.One patient complained of dizziness and one presented cutaneous eruption,the symptoms were mild and recovered spontaneously.The efficacy of ALA was positively correlated with course of treatment,the severity of nervous symptoms,decline of blood glucose and blood glucose level before treatment (r =0.125,0.602,0.150,0.172,all P ＜0.05),and negatively correlated with the urine microalbuminuria ( r =- 0.200,P ＜ 0.01 ).Conclusions α-lipoic acid can improve the symptoms of DPN in type 2 diabetic patients effectively and safely,especially for numbness,sting sensation.